Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Axogen, Inc.
< Previous
1
2
Next >
Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock
January 21, 2026
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen Announces Proposed Public Offering of Common Stock
January 21, 2026
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025
January 12, 2026
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc. to Participate in the J.P. Morgan 2026 Healthcare Conference
December 17, 2025
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx)
December 03, 2025
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
November 04, 2025
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc. Reports Third Quarter 2025 Financial Results
October 29, 2025
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc. to Report 2025 Third Quarter Financial Results on October 29, 2025
October 15, 2025
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
August 27, 2025
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen Provides Update on FDA Review Timeline for Avance Nerve Graft
August 25, 2025
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc. Reports Second Quarter 2025 Financial Results
August 05, 2025
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc. to participate at the Canaccord Genuity 45th Annual Growth Conference
July 29, 2025
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc. to report 2025 second quarter financial results on August 5, 2025
July 22, 2025
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc to Participate at Goldman Sachs Global Healthcare Conference
May 28, 2025
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc. Reports 2025 First Quarter Financial Results
May 08, 2025
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen Announces Chief Financial Officer Transition
May 08, 2025
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc. to report 2025 first quarter financial results on May 8, 2025
April 24, 2025
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen Announces Appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy, and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
March 24, 2025
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc. To Host Analyst & Investor Day on March 4th
February 25, 2025
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial Results
February 25, 2025
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025
February 11, 2025
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen Announces Appointment of Jesse Bishop as Vice President of Regulatory Affairs and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 03, 2025
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 10, 2025
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2024
January 10, 2025
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update
November 07, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024
October 24, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®
September 06, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(C)(4)
September 03, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc. Announces New Leadership Appointments
August 08, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
Axogen, Inc. Reports Second Quarter 2024 Financial Results
August 08, 2024
From
Axogen, Inc.
Via
GlobeNewswire
Tickers
AXGN
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
